American Heart Association
Top news from AHA: ISCHEMIA, dapagliflozin for HF, gout drug post-MI
Healio and Cardiology Today reported live from the American Heart Association Scientific Sessions in Philadelphia, bringing readers the latest research and breaking news in cardiology.
Type 2 MI confers elevated risk for death within 1-year follow-up
PHILADELPHIA — Patients with type 2 MI are at greater risk for recurrent CV events and death within the first year of follow-up compared with patients experiencing type 1 MI, according to findings presented at the American Heart Association Scientific Sessions.
Implantable cardiac device infections affect cost, quality of life, mortality
PHILADELPHIA — In a new analysis from the WRAP-IT trial, patients with cardiac implantable electronic devices, or CIEDs, who had major infections from their devices had higher rates of mortality, higher costs and worse quality of life compared with those who did not.
COSMIC-HF: Omecamtiv mecarbil may improve diastolic function, pulmonary pressures in HF
PHILADELPHIA — Omecamtiv mecarbil, a selective cardiac myosin activator, improved diastolic function and pulmonary pressures without worsening diastolic filling in patients with chronic HF and reduced systolic function, according to data presented at the American Heart Association Scientific Sessions.
Surgical AVR beneficial in very severe asymptomatic aortic stenosis
PHILADELPHIA — Among patients with very severe but asymptomatic aortic stenosis, surgical aortic valve replacement was linked to lower rates of operative mortality or CV death compared with conservative care, according to the RECOVERY trial.
Poverty, not distance to facility, confers cardiac rehab attrition
PHILADELPHIA — Neighborhood poverty may be a major factor for early termination of cardiac rehabilitation in New York City, whereas distance to rehabilitation facility may not be, according to the findings presented at the American Heart Association Scientific Sessions.
In cardiac arrest without STEMI, timing of angiography does not impact 1-year outcomes
PHILADELPHIA — Immediate coronary angiography and delayed coronary angiography conferred similar outcomes at 1 year in patients resuscitated from cardiac arrest but without STEMI, according to new data from the COACT trial presented at the American Heart Association Scientific Sessions.
Prior preeclampsia confers increased CVD risk for older women
PHILADELPHIA — Older women with prior preeclampsia are at elevated risk for future CV diagnoses and incidence of arterial stiffness and hypertension, according to findings presented at the American Heart Association Scientific Sessions.
High-intensity interval training safe, effective for older adults
PHILADELPHIA — Compared with moderate-intensity continuous training and controls who received advice based on national physical fitness standards in Norway, 5 years of supervised high-intensity interval training was associated with improved rates of all-cause mortality in older adults.
Social support plays important role in improving CV health of transgender adults
PHILADELPHIA — Transgender and gender-nonconforming adults who experience discrimination are more likely to report increased CV risk factors, such as excessive drinking and short sleep, but social support from family members may weaken the association.